JC
Insider
Justin Chakma
Chief Business OfficerJustin Chakma (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SPRY. The largest single filing was $1.5M of SPRY (166,380 sh across 2 lots, as filed), executed Nov 12 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 12 2025
Filed Nov 14 2025
Volume by month
Buys $0
Sells $7.2M
Shares × price, as filed · by filing month · past 24 months
Most traded names
SPRY
SPRY
0 buys · 6 sells
6 filings
Recent filings
SPRYSALE
ARS Pharmaceuticals, Inc.
View filing →
$1.5M166,380 sh across 2 lots
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $1.8M
144,605 sh across 2 lots
Exec Dec 12 2024
Filed Dec 13 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $658K
50,000 sh × $13.15
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $2.0M
144,640 sh across 3 lots
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $1.2M
90,000 sh across 2 lots
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $1.4M
100,000 sh across 3 lots
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET